Cargando…
Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer
Initially thought as being non-immunogenic, recombinant AAVs have emerged as efficient vector candidates for treating monogenic diseases. It is now clear however that they induce potent immune responses against transgene products which can lead to destruction of transduced cells. Therefore, developi...
Autores principales: | Adriouch, Sahil, Franck, Emilie, Drouot, Laurent, Bonneau, Carole, Jolinon, Nelly, Salvetti, Anna, Boyer, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202221/ https://www.ncbi.nlm.nih.gov/pubmed/22046170 http://dx.doi.org/10.3389/fmicb.2011.00199 |
Ejemplares similares
-
Immunological Tolerance to Muscle Autoantigens Involves Peripheral Deletion of Autoreactive CD8(+) T Cells
por: Franck, Emilie, et al.
Publicado: (2012) -
Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation
por: Schwarz, Nicole, et al.
Publicado: (2012) -
Immunology of AAV-Mediated Gene Transfer in the Eye
por: Willett, Keirnan, et al.
Publicado: (2013) -
A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 In Vivo
por: Gondé, Henri, et al.
Publicado: (2021) -
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019)